Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
18.20
-0.30 (-1.62%)
At close: Nov 20, 2024, 4:00 PM
18.19
-0.01 (-0.05%)
After-hours: Nov 20, 2024, 7:27 PM EST
Aligos Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 68 | 50 | 41 | 506 | 1,054 | - | |
| Market Cap Growth | -14.83% | 21.95% | -91.93% | -52.00% | - | - | |
| Enterprise Value | 2 | -9 | -88 | 276 | 1,180 | - | |
| Last Close Price | 18.20 | 16.60 | 23.82 | 296.75 | 691.25 | - | |
| PS Ratio | 18.11 | 3.20 | 2.93 | 116.05 | - | - | |
| PB Ratio | 1.21 | 0.54 | 0.39 | 2.74 | 4.79 | - | |
| P/TBV Ratio | 0.55 | 0.54 | 0.39 | 2.74 | 4.79 | - | |
| EV/Sales Ratio | 0.29 | - | - | 63.34 | - | - | |
| Debt / Equity Ratio | 0.18 | 0.12 | 0.12 | 0.08 | 0.06 | 0.12 | |
| Asset Turnover | 0.07 | 0.10 | 0.07 | 0.02 | - | - | |
| Quick Ratio | 3.58 | 5.68 | 3.80 | 4.90 | 8.04 | 8.52 | |
| Current Ratio | 3.81 | 5.90 | 4.03 | 5.25 | 8.26 | 8.70 | |
| Return on Equity (ROE) | -146.69% | -89.48% | -66.55% | -63.41% | -64.37% | -51.25% | |
| Return on Assets (ROA) | -67.32% | -36.64% | -31.93% | -32.04% | -29.70% | -26.61% | |
| Return on Capital (ROIC) | -93.25% | -49.73% | -38.64% | -37.11% | -33.54% | -29.15% | |
| Earnings Yield | -113.92% | -176.22% | -235.41% | -25.37% | -10.30% | - | |
| FCF Yield | -125.99% | -158.81% | -196.90% | -23.04% | -7.24% | - | |
| Buyback Yield / Dilution | -246.07% | -50.51% | -7.13% | -299.02% | -397.62% | -68.42% | |
| Total Shareholder Return | -246.07% | -50.51% | -7.13% | -299.02% | -397.62% | -68.42% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.